LPCAT2 and colorectal cancer: In colorectal cancer cell lines, LPLAT9 expression supported increased lipid droplet accumulation and imparted resistance to chemotherapeutic drug-induced ER stress and caspase activation in vitro and impaired immunogenic anticancer responses in vivo (134, 135).